Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew David J. Pearson, MD, FRCP, DCh
University of Newcastle Upon-Tyne
- Ann Barrett
University of Glasgow
Study Chair - Jack van Hoff, MD
Yale University
- Janice A. Kohler, MD, FRCP
University Hospital Southampton NHS Foundation Trust
- Kevin Murray, MD
Mercy Regional Cancer Center at Mercy Medical Center
- Robert P. Castleberry, MD
University of Alabama at Birmingham
- S. J. Keith Holmes, DO
St. George's Hospital
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Our Lady'S Hospital for Sick Children
Dublin, Ireland
- Birmingham Children'S Hospital
Birmingham, England, United Kingdom
- Institute of Child Health at University of Bristol
Bristol, England, United Kingdom
- Addenbrooke'S Hospital at Cambridge University Hospitals Nhs Foundation Trust
Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James'S University Hospital
Leeds, England, United Kingdom
- Leicester Royal Infirmary
Leicester, England, United Kingdom
- Royal Liverpool Children'S Hospital, Alder Hey
Liverpool, England, United Kingdom
- Great Ormond Street Hospital for Children Nhs Trust
London, England, United Kingdom
- Royal London Hospital
London, England, United Kingdom
- Central Manchester and Manchester Children'S University Hospitals Nhs Trust
Manchester, England, United Kingdom
- Sir James Spence Institute of Child Health
Newcastle upon Tyne, England, United Kingdom
- Queen'S Medical Centre
Nottingham, England, United Kingdom
- Oxford Radcliffe Hospital
Oxford, England, United Kingdom
- Children'S Hospital - Sheffield
Sheffield, England, United Kingdom
- Southampton General Hospital
Southampton, England, United Kingdom
- Royal Marsden Nhs Foundation Trust - Surrey
Sutton, England, United Kingdom
- Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, United Kingdom
- Royal Aberdeen Children'S Hospital
Aberdeen, Scotland, United Kingdom
- Royal Hospital for Sick Children
Edinburgh, Scotland, United Kingdom
- Beatson Oncology Centre
Glasgow, Scotland, United Kingdom
- Royal Hospital for Sick Children
Glasgow, Scotland, United Kingdom
- Childrens Hospital for Wales
Cardiff, Wales, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 1995
- Primary completion
- —
- Completion
- —
- Last update posted
- 17 Sept 2013
- Registered enrollment
- —
- Registry id
- NCT00276731
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.